Home > Annual Financials > IOL CHEMICALS AND PHARMACEUTICALS

IOL CHEMICALS AND PHARMACEUTICALS Financial Statement Analysis
[BOM: 524164|NSE : IOLCP]

The Revenues of IOL CHEMICALS AND PHARMACEUTICALS have decreased by -2.51% YoY .
The Earnings Per Share (EPS) of IOL CHEMICALS AND PHARMACEUTICALS has decreased by -84.98 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

IOL CHEMICALS AND PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524164|NSE : IOLCP]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Revenues ₹2,079 Cr₹2,133 Cr₹2,217 Cr₹2,184 Cr
Expenses ₹1,877 Cr₹1,902 Cr₹1,991 Cr₹1,926 Cr
Operating Profit (Excl OI) ₹202 Cr₹231 Cr₹226 Cr₹258 Cr
Other Income ₹22 Cr₹30 Cr₹26 Cr₹32 Cr
Interest ₹15 Cr₹16 Cr₹16 Cr₹8.29 Cr
Depreciation ₹72 Cr₹63 Cr₹46 Cr₹43 Cr
Profit Before Tax ₹138 Cr₹182 Cr₹189 Cr₹225 Cr
Profit After Tax ₹101 Cr₹134 Cr₹139 Cr₹168 Cr
Consolidated Net Profit ₹101 Cr₹134 Cr₹139 Cr₹168 Cr
Earnings Per Share (Rs)₹3.44₹22.90₹23.70₹28.56
PAT Margin (%)4.866.306.287.68
ROE(%)6.138.629.6012.04
ROCE(%)8.8612.2413.5716.25
Total Debt/Equity(x)0.070.020.050.03

Key Financials

Market Cap : ₹ 2,943.8 Cr
Revenue (TTM) : ₹ 2,079.2 Cr
Net Profit(TTM) : ₹ 101.1 Cr
EPS (TTM) : ₹ 3.4
P/E (TTM) : 29.1

Industry Peers & Returns1W1M1Y
IOL CHEMICALS AND PHARMACEUTICALS 8.5% 7.4% 19.1%
SUN PHARMACEUTICAL INDUSTRIES -4.3% -3% -0.7%
DIVIS LABORATORIES -3.3% -7.4% 34.1%
CIPLA -4.4% -0.5% 0.7%
TORRENT PHARMACEUTICALS 1.4% 10.1% 17.9%
DR REDDYS LABORATORIES -5.2% -5.7% -5.9%
MANKIND PHARMA 0.8% 8.4% 26.4%
ZYDUS LIFESCIENCES -3.1% -5.1% -22.2%
LUPIN -4.9% -4.6% 0.9%


IOL CHEMICALS AND PHARMACEUTICALS Revenues
[BOM: 524164|NSE : IOLCP]

Y-o-Y

-2.51 %

5 Yr CAGR

-1.63 %

Years Revenues % Change
Mar2025 ₹2,079 Cr
-2.51
Mar2024 ₹2,133 Cr
-3.80
Mar2023 ₹2,217 Cr
1.52
Mar2022 ₹2,184 Cr -


IOL CHEMICALS AND PHARMACEUTICALS Operating Profit
[BOM: 524164|NSE : IOLCP]

Y-o-Y

-12.27 %

5 Yr CAGR

-7.82 %

Years Operating Profit % Change
Mar2025 ₹202 Cr
-12.27
Mar2024 ₹231 Cr
2.18
Mar2023 ₹226 Cr
-12.63
Mar2022 ₹258 Cr -

Operating Margins
Y-o-Y

-9.99 %

5 Yr CAGR

-6.31 %

Years Operating Margin% % Change
Mar2025 9.73%
-9.99
Mar2024 10.81%
6.19
Mar2023 10.18%
-13.95
Mar2022 11.83% -

IOL CHEMICALS AND PHARMACEUTICALS Profit After Tax
[BOM: 524164|NSE : IOLCP]

Y-o-Y

-24.82 %

5 Yr CAGR

-15.53 %

Years Profit After Tax % Change
Mar2025 ₹101 Cr
-24.82
Mar2024 ₹134 Cr
-3.39
Mar2023 ₹139 Cr
-17.02
Mar2022 ₹168 Cr -

PAT Margins
Y-o-Y

-22.86 %

5 Yr CAGR

-14.15 %

Years PAT Margin(%) % Change
Mar2025 4.86 %
-22.86
Mar2024 6.3 %
0.32
Mar2023 6.28 %
-18.23
Mar2022 7.68 % -

IOL CHEMICALS AND PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524164|NSE : IOLCP]

Y-o-Y

-84.98 %

5 Yr CAGR

-50.61 %

Years EPS % Change
Mar2025 ₹3.44
-84.98
Mar2024 ₹23
-3.38
Mar2023 ₹24
-17.02
Mar2022 ₹29 -

IOL CHEMICALS AND PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524164|NSE : IOLCP]

Y-o-Y

-27.61 %

5 Yr CAGR

-18.31 %

Years ROCE % Change
Mar2025 8.86%
-27.61
Mar2024 12.24%
-9.80
Mar2023 13.57%
-16.49
Mar2022 16.25% -

IOL CHEMICALS AND PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹100.3
Current MarketCap: ₹ 2,943.8 Cr
Updated EOD on :Aug 01,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
IOL CHEMICALS AND PHARMACEUTICALS

8.5%

7.4%

19.1%

SENSEX

-1.1%

-3.4%

-1.1%

IOL CHEMICALS AND PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE HEALTHCARE -2.4% -0% 10.2%
BSE SMALLCAP -2.5% -3.5% -5.1%
No NSE index found

You may also like the below Video Courses


FAQ about IOL CHEMICALS AND PHARMACEUTICALS Financials


How the annual revenues of IOL CHEMICALS AND PHARMACEUTICALS have changed ?

The Revenues of IOL CHEMICALS AND PHARMACEUTICALS have decreased by -2.51% YoY .

How the Earnings per Share (EPS) of IOL CHEMICALS AND PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of IOL CHEMICALS AND PHARMACEUTICALS has decreased by -84.98 % YoY .